Search results
Results from the WOW.Com Content Network
Methyl-1-testosterone (M1T; developmental code name SC-11195), also known as 17α-methyl-4,5α-dihydro-δ 1-testosterone (17α-methyl-δ 1-DHT) or 17α-methyl-5α-androst-1-en-17β-ol-3-one, as well as methyldihydroboldenone, is a synthetic and orally active anabolic–androgenic steroid (AAS) [1] which was never marketed for medical use.
Methyltestosterone, sold under the brand names Android, Metandren, and Testred among others, is an androgen and anabolic steroid (AAS) medication which is used in the treatment of low testosterone levels in men, delayed puberty in boys, at low doses as a component of menopausal hormone therapy for menopausal symptoms like hot flashes, osteoporosis, and low sexual desire in women, and to treat ...
1-Testosterone (abbreviated and nicknamed as 1-Testo, 1-T), also known as δ 1-dihydrotestosterone (δ 1-DHT), as well as dihydroboldenone, is a synthetic anabolic–androgenic steroid (AAS) and a 5α-reduced derivative of boldenone (Δ1-testosterone). It differs from testosterone by having a 1(2)-double bond instead of a 4(5)-double bond in ...
2-Methyl-1-butanol (2M1B) Secondary 137-32-6 2-methylpropan-1-ol: 2-Methyl-1-propanol (2M1P), Isobutanol Primary 78-83-1 2-Methylbutan-2-ol: 2-Methyl-2-butanol (2M2B), tert-Amyl alcohol (TAA, tert-amylol) Tertiary 75-85-4 2-Methylpropan-2-ol: 2-Methyl-2-propanol (2M2P), tert-Butyl alcohol ((TBA), tert-butanol), t-BuOH Tertiary 75-65-0 2 ...
This page was last edited on 14 January 2025, at 06:10 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
Trestolone, also known as 7α-methyl-19-nortestosterone (MENT), is an experimental androgen/anabolic steroid (AAS) and progestogen medication which has been under development for potential use as a form of hormonal birth control for men and in androgen replacement therapy for low testosterone levels in men but has never been marketed for medical use.
CDMT was the first original product of Jenapharm, an East German pharmaceutical company.It was patented in 1961. The idea of combining the structures of 4-chlorotestosterone (clostebol) and metandienone originated with chemist Albert Stachowiak.
MTHFR is the rate-limiting enzyme in the methyl cycle, which includes the conversion of homocysteine into methionine. Defects in variants of MTHFR can therefore lead to hyperhomocysteinemia. [9] There are two common variants of MTHFR deficiency. In the more significant of the two, the individual is homozygous for the 677T polymorphism.